{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Krystal Biotech, Inc."},"Symbol":{"label":"Symbol","value":"KRYS"},"Address":{"label":"Address","value":"2100 WHARTON STREET,SUITE 701, PITTSBURGH, Pennsylvania, 15203, United States"},"Phone":{"label":"Phone","value":"+1 412 586-5830"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future."},"CompanyUrl":{"label":"Company Url","value":"https://www.krystalbio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"George Chen","title":"Manager-Information Technology & CSV"},{"name":"Krish S. Krishnan","title":"Chairman, President & Chief Executive Officer"},{"name":"Ram Kamineni","title":"Senior VP-CMC & Technical Operations"},{"name":"Suma M. Krishnan","title":"Director, President-Research & Development"},{"name":"Trevor Parry","title":"Vice President-Research & Scientific Affairs"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}